Marine-derived bioactive peptides are promising natural enzyme inhibitors, but their functional robustness and inhibition behavior require experimental validation. Golden pompano (Trachinotus anak) muscle proteins were subjected to ultrasound-assisted neutral protease–papain hydrolysis, activity-guided ultrafiltration, LC–MS/MS identification, and synthetic-peptide validation. The <3 kDa ultrafiltration fraction showed the highest activity (75.43% tyrosinase inhibition and 51.40% apparent Cu2+ chelation) and was selected for LC–MS/MS. Five candidate peptides were synthesized after stepwise prioritization. VTPPHVE showed the lowest IC50 value for tyrosinase inhibition (113.41 μM) and exhibited the strongest apparent Cu2+-chelating activity among the synthesized peptides (141.54 μM). VTPPHVE retained comparable inhibitory activity after pH 2–10 treatment and heating at 20–100 °C, and showed detectable apparent activity after simulated gastrointestinal treatments, although the digested samples were not normalized to an equivalent peptide concentration at the assay stage and digestion-fluid blanks were not included. Enzyme kinetics indicated mixed-type inhibition, with a concentration-dependent decrease in apparent Vmax and an increase in apparent Km. Molecular docking placed VTPPHVE in an inter-chain surface region spanning H-subunit chains A and B, while a 100 ns molecular dynamics simulation supported the dynamic persistence of the docking-derived model after initial conformational adjustment. These results identify VTPPHVE as a marine fish-derived tyrosinase-inhibitory peptide and extend its characterization from sequence-level discovery to functional activity retention, enzyme kinetics, and exploratory structural modeling.
No takes yet. Share an insight, caveat, or question.
An et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: